FKBP9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.882000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.367800E-01
Normal-vs-Stage2
2.629800E-01
Normal-vs-Stage3
7.178000E-01
Normal-vs-Stage4
9.044200E-02
Stage1-vs-Stage2
3.019800E-03
Stage1-vs-Stage3
7.748000E-01
Stage1-vs-Stage4
6.475300E-03
Stage2-vs-Stage3
4.787200E-01
Stage2-vs-Stage4
3.108400E-01
Stage3-vs-Stage4
2.150800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.029400E-01
Normal-vs-AfricanAmerican
1.143360E-01
Normal-vs-Asian
5.220600E-01
Caucasian-vs-AfricanAmerican
6.613000E-01
Caucasian-vs-Asian
4.119800E-01
AfricanAmerican-vs-Asian
2.442200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.443600E-01
Normal-vs-Female
1.938390E-01
Male-vs-Female
6.796600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.617200E-01
Normal-vs-Age(41-60Yrs)
1.783840E-01
Normal-vs-Age(61-80Yrs)
3.476400E-01
Normal-vs-Age(81-100Yrs)
5.067000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.761800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.400200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.604600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.953930E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.557800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.362200E-01
Normal-vs-Daily Drinker
4.911000E-01
Normal-vs-Weekly Drinker
2.562800E-01
Normal-vs-Occasional Drinker
1.710840E-01
Normal-vs-Social Drinker
2.296000E-01
Non Drinker-vs-Daily Drinker
2.546600E-01
Non Drinker-vs-Weekly Drinker
7.949600E-02
Non Drinker-vs-Occasional Drinker
2.688400E-02
Non Drinker-vs-Social Drinker
6.706200E-02
Daily Drinker-vs-Weekly Drinker
9.830200E-01
Daily Drinker-vs-Occasional Drinker
6.539600E-01
Daily Drinker-vs-Social Drinker
9.834800E-01
Weekly Drinker-vs-Occasional Drinker
6.042400E-01
Weekly Drinker-vs-Social Drinker
9.988000E-01
Occasional Drinker-vs-Social Drinker
5.869400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.404600E-01
Normal-vs-Grade 2
1.299970E-02
Normal-vs-Grade 3
6.962300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.321800E-01
Grade 1-vs-Grade 3
2.904000E-01
Grade 1-vs-Grade 4
3.404600E-01
Grade 2-vs-Grade 3
5.179400E-01
Grade 2-vs-Grade 4
1.299970E-02
Grade 3-vs-Grade 4
6.962300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.073800E-01
Normal-vs-NonDiabetic
2.832800E-01
Diabetic-vs-NonDiabetic
2.580800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.570020E-01
Normal-vs-NoPancreatitis
2.608200E-01
Pancreatitis-vs-NoPancreatitis
6.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.951400E-01
Normal-vs-N1
2.506200E-01
N0-vs-N1
5.238100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.929780E-01
Normal-vs-TP53-NonMutant
5.275400E-01
TP53-Mutant-vs-TP53-NonMutant
7.818400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
